Market Place
Filter By Unselect All
Sub Category Unselect See All
Country Unselect See All
Companies Unselect See All
AbbVie Contract (1)
AvacaPharma (1)
Capsugel (1)
Crystec Pharma (1)
Custom Pharma (1)
GRAM Laboratory (1)
GVK Biosciences (1)
PharmaVize NV (1)
Pierre Fabre (1)
Ropack Inc (1)
Selected Filter(s): Reset All
- Category Reset
- Sub Category Reset
- Country Reset
Solubility-Enhanced Dosage Forms Development 
API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement
Quotient Sciences has almost 30 years of experience developing a breadth of formulations across a range of indications.
Website
Formulplex®
API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement
It is a complexation process to improve the solubility and bioavailability of a poorly soluble active ingredient, This complexation process by cyclodextrins differs from other complexation processes. It is performed in supercritical CO2 medium.
Improvement of Bioavailability
API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement
Glatt can optimize the active substance release and bioavailability by specific optimized formulation and process methods depending on the physico-chemical property of the active substance.
Solubility Screening / Bio-Availability
API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement
Solubility screening, bio-availability enhancement to accelerate your drug development and approval.
Lipidic Vehicles Development
API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement
Quotient Sciences has almost 30 years of experience developing a breadth of formulations across a range of indications.
Micropx™- Micro Pelletizing Technology
API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement
The Glatt MicroPX™ technology (micro pelletizing technology) is a continuous fluidized bed agglomeration procedure for the manufacture of pellets and micropellets with a very high active ingredient content.
Complexes Development
API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement
Quotient Sciences has almost 30 years of experience developing a breadth of formulations across a range of indications.
Improved Performance of Poorly Soluble Drugs
API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement
With over 40% of new drug substances exhibiting poor aqueous solubility, a major task for industrial pharmaceutical scientists has been to explore alternative procedures for overcoming this characteristic which can compromise the bioavailability, and thereby detract from optimising the clinical
Solubility Characteristics of Drug
API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement
SUSHEN Medicamentos (SUSHEN), is a global company of end-to-end pharmaceutical services with focus on drug delivery research and product development. SUSHEN’s expertise can bring a complex formulation project in to clinical and bioequivalence with superior quality, innovative solution.
Spray-Dried Formulation Development
API & Drug Product Development >> Preformulation & Material Science >> Solubility Assessment & Enhancement
Quotient Sciences has a proven track record of developing and manufacturing SDDs to overcome your poor drug solubility and delivery challenges. We tailor the development of your SDD toward the specific physical and biopharmaceutics properties.
